A 21 Day Pharmacokinetics Study in Papulopustular Rosacea
NCT02028286
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
25
Enrollment
INDUSTRY
Sponsor class
Conditions
Papulopustular Rosacea
Interventions
DRUG:
CLS001
Sponsor
Maruho Co., Ltd.